Arch Venture Partners raises over $3bn for Fund XIII
The fund’s investments to date include ArsenalBio, Metsera, Mirador Therapeutics and Xaira Therapeutics Fund XIII follows the nearly $3bn Fund ...
Tag: 3bn
Popular News
-
’Prioritize clarity, strategy and people’: Magdalena Wczesna’s Key Pieces of Mastering Sales Strategies for Startups
-
A Fun Night at TRUESDAYS in Prague
-
Fidelity Investments raises $250m for its first VC fund
-
Budapest-based Voovo raises €500k pre-seed to scale microlearning in education
-
FinTech Growth: Solve Real Problems, Stay Authentic – Insights from Remco Veenenberg
